News

People with metabolic dysfunction-associated steatotic liver disease (MASLD) who drink heavily at least once a month face higher odds of advanced liver scarring than…

Offering jail-based hepatitis C programs that include testing, treatment, and post-release support could cut new hepatitis C virus (HCV) infections in half among people…

An artificial intelligence (AI) tool that analyzes patterns in blood molecules may help distinguish people with primary sclerosing cholangitis (PSC) and inflammatory bowel disease…

Testing for bilirubin, a liver damage marker, in urine is not reliable for screening or diagnosing cholestasis (slowed flow of the digestive fluid bile)…

An upcoming portion of an ongoing clinical trial that will test Wave Life Sciences’ WVE-007 in adults with obesity and related health problems will…

Most infants with the rare liver disease biliary atresia (BA) show signs of a previous rotavirus infection, suggesting the common childhood virus may play…

Mirum Pharmaceuticals is making progress with a quartet of late-stage clinical trials designed to test brelovitug, the company’s experimental therapy for chronic hepatitis…

Primary biliary cholangitis (PBC) patients who have irreversible liver scarring that affects the organ’s function are more likely to experience liver function recovery if…

Researchers in China have developed and validated a new prediction model that can help distinguish pregnant women with intrahepatic cholestasis of pregnancy (ICP) who…

Two proteins called S100A11 and HK2 contribute to the abnormal buildup of fat in the liver that characterizes steatotic liver disease (SLD), according to…